Journal Articles on Mesothelioma: 'Benign' Category
June 17th, 2008. Benign multicystic peritoneal mesothelioma in a cesarean-section scar presenting as a fungating mass
This unusual presentation may point to a traumatic or inflammatory etiology, although seeding of the wound during the previous surgeries is a more likely postulate. A pertinent review of the literature on benign multicystic mesothelioma is also presented.
May 15th, 2008. Cytology of benign multicystic peritoneal mesothelioma in peritoneal washings
Conclusion: The combination of cytology of the peritoneal washing, histology (cell block and surgical specimen) and clinical history allow differentiation of BMPM from other cystic lesions (cystic lymphangioma and malignant mesothelioma).
April 4th, 2008. The diagnostic value of Ki-67 and repp86 in distinguishing between benign and malignant mesothelial proliferations
Conclusions: Used in combination, Ki-67 and repp86 appear to be useful markers in differentiating MM from benign reactive MH.
February 27th, 2008. I-131 accumulation in a benign cystic mesothelioma in a patient with follicular thyroid cancer
Extrathyroidal I-131 accumulation has been reported in various sites, such as ectopic gastric mucosa, gastrointestinal and urinary tract abnormalities, cysts (mammary, liver, kidney, and ovaries), and inflammation and infection foci. We report a case of focal I-131 accumulation in a benign cystic mesothelioma in a patient with follicular thyroid cancer.
October 3rd, 2007. Benign Peritoneal Multicystic Mesothelioma Diagnosed and Treated by Laparoscopic Surgery
In this paper, we present the case of a young woman with benign multicystic mesothelioma in which only laparoscopy led to the appropriate diagnosis. Subsequently, the tumor was removed by laparoscopic surgery.
June 5th, 2007. Benign peritoneal cystic mesothelioma as differential diagnose of an ovarian dependant tumor. Case report and review of the literature
Despite the low incidence of this tumoration the gynecologist must be familiar with this disease, because of the high recurrence. Nowadays, steroid hormone receptors typification seems to play an important role to control the recurrence of this tumoration.
April 19th, 2007. Chemokine receptors are infrequently expressed in malignant and benign mesothelial cells
This finding suggests a major role for an autocrine chemokine pathway in leukocytes but not in MM cells. The increased monocyte infiltration and their higher chemokine receptor expression in MM effusions may have a tumor-promoting rather than tumor-inhibiting effect.
March 30th, 2007. Value of antimesothelioma HBME-1 in the diagnosis of inflammatory and malignant pleural effusions
33%) cases; the staining pattern in metastatic adenocarcinoma cells was thin membrane and focal cytoplasmic. HBME-1 has a moderate sensibility and specificity for mesothelial cells and can be used as part of a panel for differentiation of malignant and reactive mesothelial cells from adenocarcinoma in pleural effusions.
March 23rd, 2007. Asbestos-related lung disease
Because exposure to cigarette smoke increases the risk of developing lung cancer in patients with a history of asbestos exposure, smoking cessation is essential. Patients with asbestosis or lung cancer should receive influenza and pneumococcal vaccinations.
Posted in Benign, Causation, Diffuse mesothelioma, Epidemiological, Full Archive, General, Occupational Asbestos Exposure, Pleural, Treatment, Type of Assessment:, Type of Mesothelioma: | No Comments »
February 13th, 2007. Benign cystic mesothelioma presenting as a huge pelvic mass–a case report
All tumoral markers were within normal range. Surgical [corrected] treatment consisted of radical excision of the mass and the prognosis was good [corrected].
February 3rd, 2007. Asbestos-related diseases
br Abstract This chapter presents a bibliographic review of asbestos-related diseases. The latest diagnostic, radiological, computed tomography and lung function aspects of benign pleural disease, asbestosis, occupational lung cancer and mesothelioma are discussed.
December 14th, 2006. Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: a systematic review of published reports
Conclusions: Immunohistochemistry is of limited value, but newer diagnostic methods may be useful additions in this area of pathology. The diagnostic importance of histological features seen on plain tissue sections is emphasized as vital for correctly differentiating between benign pleural disease and malignant pleural mesothelioma.
November 1st, 2006. Solitary fibrous tumor of the pleura
Conclusions: Benign SFTP has a high cure rate and an 8% local recurrence rate that is usually amenable to curative re-excision. Malignant SFTP, especially the more common sessile type, has a 63% recurrence rate even with complete resection. The majority of patients with recurrent disease die of the tumor within 2 years. Nevertheless, the overall long-term cure rate for all patients is 88% to 92%.
September 29th, 2006. Benign multicystic peritoneal mesothelioma: A case report and review of the literature
Complete resection of the lesion was performed. The patient had an uneventful recovery and had no recurrence two years after surgery.
July 24th, 2006. Multilocular peritoneal inclusion cyst - a case report
We report a case of a 26-year old female who underwent Caesarean section during which cysts which were multiloculated, thin-walled and filled with serous fluid, were incidentally discovered. Its histopathologic examination established the diagnosis.
July 19th, 2006. Imaging of pleural disease
The conditions covered include benign and malignant pleural thickening, pleural effusions, empyema and pneumothoraces. The relative merits of CT, MRI and PET in the assessment of these conditions and the role of image-guided intervention are discussed.
Posted in Benign, CT or CAT scan, Diagnosis & Differentiation, Full Archive, MRI, PET Scan, Pleural, Pleural Effusion, Symptoms & Symptom Management, Type of Assessment:, Type of Mesothelioma: | No Comments »
March 10th, 2006. Benign Peritoneal Cystic Mesothelioma
Conclusions: Lack of consistent definitions, various treatment approaches, and mostly short follow-up times make it difficult to draw any firm conclusions from published reports. The natural history of this rare disease is less than well clarified. When possible, in an individual patient, surgical resection with curative intent seems to be the treatment of choice.
February 23rd, 2006. Cell proliferation rate and telomerase activity in the differential diagnosis between benign and malignant mesothelial proliferations
Conclusion: As a result, being cheap and simple methods, Ki-67 and hTERT immunohistochemistries can be used in differentiating malignant and benign mesothelial lesions in routine formalin-fixed, paraffin-embedded material.
January 9th, 2006. Benign mesothelioma of the appendix: an incidental finding in a case of sigmoid diverticular disease
Microscopy revealed a benign mesothelioma. The patient remains symptom free to date.
December 23rd, 2005. Argyrophilic nucleolar organizer regions in benign and malignant mesothelial lesions
This differentiation is based primarily on the mean number of AgNOR-dots per cell rather than number of AgNOR-positive cells. AgNOR is highly sensitive, specific and cost-effective technology which can be used as an ancillary diagnostic approach for distinguishing between reactive and/or hyperplastic changes of mesothelium as well as in differential diagnosis of epithelial type mesothelioma.
|
|  |
